Verapamil and Alzheimer's Disease: Past, Present, and Future.
Alzheimer’s disease
emotion
learning
memory
verapamil
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2020
2020
Historique:
received:
15
02
2020
accepted:
14
04
2020
entrez:
21
5
2020
pubmed:
21
5
2020
medline:
21
5
2020
Statut:
epublish
Résumé
Verapamil is a phenylalkylamine class calcium channel blocker that for half a century has been used for the treatment of cardiovascular diseases. Nowadays, verapamil is also considered as a drug option for the treatment of several neurological and psychiatric disorders, such as cluster headache, bipolar disorders, epilepsy, and neurodegenerative diseases. Here, we review insights into the potential preventive and therapeutic role of verapamil on Alzheimer's disease (AD) based on limited experimental and clinical data. Pharmacological studies have shown that verapamil has a wide therapeutic spectrum, including antihypertensive, anti-inflammatory, and antioxidative effects, regulation of the blood-brain barrier function, due to its effect on P-glycoprotein, as well as adjustment of cellular calcium homeostasis, which may result in the delay of AD onset or ameliorate the symptoms of patients. However, the majority of the AD individuals are on polypharmacotherapy, and the interactions between verapamil and other drugs need to be considered. Therefore, for an appropriate and successful AD treatment, a personalized approach is more than necessary. A well-known narrow pharmacological window of verapamil efficacy may hinder this approach. It is therefore important to note that the verapamil efficacy may be conditioned by different factors. The onset, grade, and brain distribution of AD pathological hallmarks, the time-sequential appearances of AD-related cognitive and behavioral dysfunction, the chronobiologic and gender impact on calcium homeostasis and AD pathogenesis may somehow be influencing that success. In the future, such insights will be crucial for testing the validity of verapamil treatment on animal models of AD and clinical approaches.
Identifiants
pubmed: 32431612
doi: 10.3389/fphar.2020.00562
pmc: PMC7214748
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
562Informations de copyright
Copyright © 2020 Popović, Morales-Delgado, Vidal Mena, Alonso, Pascual Martínez, Caballero Bleda and Popović.
Références
Pharm Res. 2018 Feb 05;35(2):44
pubmed: 29404777
J Neurophysiol. 2009 Oct;102(4):2194-207
pubmed: 19675291
Drugs Aging. 1996 Jul;9(1):24-36
pubmed: 8818583
Stroke. 2004 Aug;35(8):1810-5
pubmed: 15232128
Mol Psychiatry. 2016 Oct;21(10):1324-32
pubmed: 27240535
Microsc Res Tech. 2002 Jun 1;57(5):365-80
pubmed: 12112443
J Neurol Sci. 1987 Jun;79(1-2):67-76
pubmed: 3612173
Front Neurol. 2015 Oct 06;6:206
pubmed: 26500603
Can J Neurol Sci. 1989 Nov;16(4 Suppl):516-27
pubmed: 2804814
Br J Clin Pharmacol. 1995 Oct;40(4):325-31
pubmed: 8554934
Exp Brain Res. 2006 Apr;170(3):368-75
pubmed: 16328269
Brain Res. 1995 Oct 9;695(1):88-91
pubmed: 8574653
Front Aging Neurosci. 2019 Dec 10;11:337
pubmed: 31920620
Neurobiol Dis. 2011 Jan;41(1):62-70
pubmed: 20816785
Curr Alzheimer Res. 2004 May;1(2):121-5
pubmed: 15975076
Br J Pharmacol. 1999 May;127(2):576-82
pubmed: 10385261
J Pharmacol Exp Ther. 1990 Oct;255(1):364-73
pubmed: 2213568
Seizure. 2017 Aug;50:173-185
pubmed: 28704741
Clin Pharmacol Ther. 1993 Sep;54(3):278-85
pubmed: 8375122
Exp Brain Res. 2007 Nov;183(3):411-6
pubmed: 17912506
Int J Neuropsychopharmacol. 2018 Feb 1;21(2):175-186
pubmed: 29020410
J Clin Invest. 2005 Nov;115(11):3285-90
pubmed: 16239972
Br J Clin Pharmacol. 1986;21 Suppl 2:97S-107S
pubmed: 3019374
J Biol Chem. 2010 Apr 23;285(17):12463-8
pubmed: 20212036
Front Aging Neurosci. 2016 Feb 23;8:31
pubmed: 26941642
FASEB J. 2019 Jun;33(6):6697-6712
pubmed: 30848934
J Pharm Pharmacol. 2011 Aug;63(8):1111-8
pubmed: 21718295
Br J Pharmacol. 1990 Jan;99(1):41-6
pubmed: 1691944
Headache. 2019 Sep;59(8):1198-1211
pubmed: 31339562
Curr Opin Nephrol Hypertens. 2005 Sep;14(5):453-9
pubmed: 16046904
Eur J Pharmacol. 2007 Nov 14;573(1-3):39-48
pubmed: 17651721
J Pharmacol Exp Ther. 1993 May;265(2):690-8
pubmed: 8496816
Headache. 2009 Jan;49(1):117-25
pubmed: 19125880
J Neurophysiol. 2003 Jun;89(6):3061-9
pubmed: 12611943
Biol Psychiatry. 2013 Sep 1;74(5):333-9
pubmed: 23273723
Alzheimers Dement. 2017 Feb;13(2):178-182.e17
pubmed: 28061328
Neurobiol Aging. 2005 Feb;26(2):157-63
pubmed: 15582745
Psychopharmacology (Berl). 2016 Jan;233(1):137-52
pubmed: 26446867
J Neurochem. 2001 Feb;76(4):1121-8
pubmed: 11181832
Int J Antimicrob Agents. 2016 Jun;47(6):421-9
pubmed: 27211826
Br J Pharmacol. 2013 Jul;169(6):1203-10
pubmed: 23638877
Jpn J Pharmacol. 1986 Aug;41(4):431-5
pubmed: 3773338
Acta Diabetol. 2020 Feb;57(2):117-131
pubmed: 31172294
J Alzheimers Dis. 2018;64(s1):S567-S610
pubmed: 29843241
Br J Clin Pharmacol. 1986;21 Suppl 2:165S-171S
pubmed: 3530299
Neuropharmacology. 2011 Feb-Mar;60(2-3):373-80
pubmed: 20950631
Expert Rev Neurother. 2016;16(1):9-15
pubmed: 26567612
Br J Pharmacol. 1983 Mar;78(3):571-7
pubmed: 6132643
Cell Mol Neurobiol. 2013 Oct;33(7):875-84
pubmed: 23824529
Dement Neurocogn Disord. 2019 Jun;18(2):33-46
pubmed: 31297134
Clin Neuropharmacol. 1993 Jun;16(3):263-5
pubmed: 8504444
Postgrad Med J. 1974 Jul;50(585):447-53
pubmed: 4469035
Brain. 2018 Jul 1;141(7):1917-1933
pubmed: 29850777
Gen Pharmacol. 1991;22(6):1147-9
pubmed: 1810811
Trends Pharmacol Sci. 1994 Dec;15(12):447-50
pubmed: 7886816
Pharmacol Res. 2018 Apr;130:385-401
pubmed: 29425728
Headache. 1983 Nov;23(6):266-77
pubmed: 6358126
N Z Med J. 1978 May 24;87(612):351-4
pubmed: 353597
Clin Pharmacol Ther. 1994 May;55(5):509-17
pubmed: 8181195
EJNMMI Res. 2012 Jan 17;2(1):1
pubmed: 22251281
Neurology. 2017 Dec 12;89(24):2447-2454
pubmed: 29117954
Int J Neurosci. 1998 Sep;95(3-4):203-36
pubmed: 9777440
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
Metab Brain Dis. 2020 Mar;35(3):503-515
pubmed: 31691145
FEBS J. 2020 Feb;287(4):612-625
pubmed: 31750987
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2604-2610
pubmed: 28368479
Ann N Y Acad Sci. 1994 Dec 15;747:382-406
pubmed: 7847686
Biochem J. 1997 Sep 1;326 ( Pt 2):539-44
pubmed: 9291129
Curr Treat Options Neurol. 2017 Jun;19(6):21
pubmed: 28456915
Brain Res. 2002 Nov 29;956(2):254-61
pubmed: 12445693
Br Med J. 1973 Feb 17;1(5850):375-8
pubmed: 4570671
World J Otorhinolaryngol Head Neck Surg. 2018 Aug 24;4(3):169-174
pubmed: 30506047
Gen Pharmacol. 1990;21(3):317-9
pubmed: 2341018
eNeuro. 2017 Aug 18;4(4):
pubmed: 28828400
Cell Calcium. 2018 Mar;70:87-94
pubmed: 28728834
PLoS One. 2014 Nov 14;9(11):e112773
pubmed: 25396737
CMAJ. 1999 Sep 7;161(5):501-6
pubmed: 10497605
Alzheimers Dement. 2011 Sep;7(5):532-9
pubmed: 21889116
Ann Neurol. 1981 Aug;10(2):122-6
pubmed: 7283399
Eur J Pharmacol. 1986 Jul 15;126(1-2):151-4
pubmed: 3758159
Int J Neurosci. 1997 Oct;91(3-4):181-8
pubmed: 9394225
Biopharm Drug Dispos. 2006 Oct;27(7):329-34
pubmed: 16892180
Mol Cells. 2011 Sep;32(3):289-94
pubmed: 21822937
Front Pharmacol. 2017 Aug 23;8:566
pubmed: 28878678
Biol Psychiatry. 2018 Jan 1;83(1):29-37
pubmed: 28751069
Biol Psychiatry. 2002 May 1;51(9):745-52
pubmed: 11983188
Lancet. 1996 Apr 27;347(9009):1141-5
pubmed: 8609748
Brain Pathol. 2007 Oct;17(4):347-53
pubmed: 17610523
Neurobiol Aging. 2014 May;35(5):1002-11
pubmed: 24268883
Gen Pharmacol. 1990;21(1):149-52
pubmed: 2153606
Trends Pharmacol Sci. 2015 Aug;36(8):506-13
pubmed: 26073420
Eur J Pharmacol. 2018 Jul 5;830:9-16
pubmed: 29679542
Am J Epidemiol. 2012 Apr 1;175(7):627-35
pubmed: 22387374
Aging Cell. 2007 Jun;6(3):307-17
pubmed: 17465978
J Alzheimers Dis. 2017;57(4):1105-1121
pubmed: 28059794
Expert Opin Drug Metab Toxicol. 2019 Jan;15(1):35-47
pubmed: 30558453
Eur J Clin Pharmacol. 1989;37(6):613-5
pubmed: 2612558
Gen Pharmacol. 1992 Jan;23(1):61-3
pubmed: 1317312
Adv Drug Deliv Rev. 2007 Aug 31;59(9-10):923-39
pubmed: 17659803
Burns. 2014 Jun;40(4):583-8
pubmed: 24182692
Ann N Y Acad Sci. 1989;568:1-4
pubmed: 2629579
J Neuropathol Exp Neurol. 2010 Oct;69(10):1034-43
pubmed: 20838242
Annu Rev Pharmacol Toxicol. 1977;17:149-66
pubmed: 326161
J Alzheimers Dis. 2013;37(2):439-51
pubmed: 23948887
J Neurosci. 2008 Jan 23;28(4):788-97
pubmed: 18216187
Nucl Med Biol. 2003 Oct;30(7):747-51
pubmed: 14499333
Med Clin North Am. 2019 Mar;103(2):263-293
pubmed: 30704681
Br Heart J. 1979 Feb;41(2):167-74
pubmed: 371644
Neurobiol Aging. 1995 Jan-Feb;16(1):5-10
pubmed: 7723935
Mol Imaging Biol. 2012 Dec;14(6):771-6
pubmed: 22476967
BMJ. 2001 Jun 16;322(7300):1447-51
pubmed: 11408299
Nat Rev Neurosci. 2002 Nov;3(11):862-72
pubmed: 12415294
Int J Neurosci. 1997 Nov;92(1-2):79-93
pubmed: 9522258
J Clin Pharmacol. 2000 Mar;40(3):219-30
pubmed: 10709150
Trends Neurosci. 2008 Sep;31(9):454-63
pubmed: 18675468
Brain Res. 1999 Feb 6;818(1):168-70
pubmed: 9914452
Autophagy. 2014;10(12):2385-6
pubmed: 25484079
Eur J Pharmacol. 1984 Oct 30;106(1):215-6
pubmed: 6529970
Brain Res. 1993 May 21;611(2):216-21
pubmed: 8392892
Prog Neurobiol. 2017 Apr;151:101-138
pubmed: 27084356
Curr Pharm Des. 2011;17(26):2771-7
pubmed: 21831040
Br Med J. 1972 Mar 11;1(5801):660-2
pubmed: 5015294
Neurol Sci. 2017 May;38(Suppl 1):45-50
pubmed: 28527055
Assay Drug Dev Technol. 2014 Mar;12(2):110-9
pubmed: 24579774
Eur Neuropsychopharmacol. 1998 May;8(2):105-11
pubmed: 9619688
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9469-E9478
pubmed: 30228120
Acta Neuropathol. 2016 May;131(5):645-58
pubmed: 26711459
J Alzheimers Dis. 2010;19(1):355-61
pubmed: 20061650
Mol Pharmacol. 1997 May;51(5):872-81
pubmed: 9145926
Curr Rheumatol Rep. 2015 Jul;17(7):43
pubmed: 25980668
Front Mol Neurosci. 2019 Aug 22;12:203
pubmed: 31507373
Neurotoxicology. 2017 Jul;61:143-187
pubmed: 28363508
Eur J Pharmacol. 2010 Dec 15;649(1-3):210-7
pubmed: 20854806
Dermatol Surg. 2015 Dec;41(12):1343-50
pubmed: 26606434
Int J Neurosci. 1997 Jun;90(1-2):87-97
pubmed: 9285290
Pharmacogenetics. 2002 Oct;12(7):535-41
pubmed: 12360104
Gen Pharmacol. 1991;22(6):1151-4
pubmed: 1667304
Chemosphere. 2017 Dec;189:466-478
pubmed: 28957764
Expert Opin Ther Targets. 2013 Oct;17(10):1203-20
pubmed: 23883298
Eur Urol. 2018 Dec;74(6):767-781
pubmed: 30237020
Neuropharmacology. 2012 Sep;63(4):685-91
pubmed: 22659089